Literature DB >> 24727052

Evaluation of circulating cathodic antigen (CCA) urine-cassette assay as a survey tool for Schistosoma mansoni in different transmission settings within Bugiri District, Uganda.

M Adriko1, C J Standley2, B Tinkitina3, E M Tukahebwa4, A Fenwick5, F M Fleming5, J C Sousa-Figueiredo6, J R Stothard7, N B Kabatereine8.   

Abstract

Diagnosis of schistosomiasis at the point-of-care (POC) is a growing topic in neglected tropical disease research. There is a need for diagnostic tests which are affordable, sensitive, specific, user-friendly, rapid, equipment-free and delivered to those who need it, and POC is an important tool for disease mapping and guiding mass deworming. The aim of present study was to evaluate the relative diagnostic performance of two urine-circulating cathodic antigen (CCA) cassette assays, one commercially available and the other in experimental production, against results obtained using the standard Kato-Katz faecal smear method (six thick smears from three consecutive days), as a 'gold-standard', for Schistosoma mansoni infection in different transmission settings in Uganda. Our study was conducted among 500 school children randomly selected across 5 schools within Bugiri district, adjacent to Lake Victoria in Uganda. Considering results from the 469 pupils who provided three stool samples for the six Kato-Katz smears, 293 (76%) children had no infection, 109 (23%) were in the light intensity category, while 42 (9%) and 25 (5%) were in the moderate and heavy intensity categories respectively. Following performance analysis of CCA tests in terms of sensitivity, specificity, negative and positive predictive values, overall performance of the commercially available CCA test was more informative than single Kato-Katz faecal smear microscopy, the current operational field standard for disease mapping. The current CCA assay is therefore a satisfactory method for surveillance of S. mansoni in an area where disease endemicity is declining due to control interventions. With the recent resolution on schistosomiasis elimination by the 65th World Health Assembly, the urine POC CCA test is an attractive tool to augment and perhaps replace the Kato-Katz sampling within ongoing control programmes.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Circulating cathodic antigen (CCA); Diagnostic methods; Intestinal schistosomiasis; Point-of-care diagnosis (POC); Rapid diagnostic test (RDT); Schistosoma mansoni; Uganda

Mesh:

Substances:

Year:  2014        PMID: 24727052     DOI: 10.1016/j.actatropica.2014.04.001

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  43 in total

1.  Cost analysis of tests for the detection of Schistosoma mansoni infection in children in western Kenya.

Authors:  Caitlin M Worrell; Monina Bartoces; Diana M S Karanja; Elizabeth A Ochola; Daniel O Matete; Pauline N M Mwinzi; Susan P Montgomery; W Evan Secor
Journal:  Am J Trop Med Hyg       Date:  2015-04-13       Impact factor: 2.345

2.  Evaluation of point-of-contact circulating cathodic antigen assays for the detection of Schistosoma mansoni infection in low-, moderate-, and high-prevalence schools in western Kenya.

Authors:  Karen T Foo; Anna J Blackstock; Elizabeth A Ochola; Daniel O Matete; Pauline N M Mwinzi; Susan P Montgomery; Diana M S Karanja; W Evan Secor
Journal:  Am J Trop Med Hyg       Date:  2015-04-13       Impact factor: 2.345

Review 3.  Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas.

Authors:  Eleanor A Ochodo; Gowri Gopalakrishna; Bea Spek; Johannes B Reitsma; Lisette van Lieshout; Katja Polman; Poppy Lamberton; Patrick M M Bossuyt; Mariska M G Leeflang
Journal:  Cochrane Database Syst Rev       Date:  2015-03-11

4.  Burden and factors associated with schistosomiasis and soil-transmitted helminth infections among school-age children in Huambo, Uige and Zaire provinces, Angola.

Authors:  Adam W Bartlett; Jose C Sousa-Figueiredo; Susana Vaz Nery; Sergio Lopes; Roelofje C van Goor; Paul Monaghan; Warren Lancaster; Rukaaka Mugizi; Elsa P Mendes
Journal:  Infect Dis Poverty       Date:  2022-06-25       Impact factor: 10.485

Review 5.  Advances in the Diagnosis of Human Schistosomiasis.

Authors:  Kosala G A D Weerakoon; Geoffrey N Gobert; Pengfei Cai; Donald P McManus
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

6.  Validation of a Point-of-Care Circulating Cathodic Antigen Urine Cassette Test for Schistosoma mansoni Diagnosis in the Sahel, and Potential Cross-Reaction in Pregnancy.

Authors:  Helena Greter; Stefanie J Krauth; Bongo N R Ngandolo; Idriss O Alfaroukh; Jakob Zinsstag; Jürg Utzinger
Journal:  Am J Trop Med Hyg       Date:  2015-11-10       Impact factor: 2.345

7.  Validity of urine-CCA cassette test and indirect haem-agglutination assay (IHA) in the detection of schistosomiasis-mansoni infection relative to microscopic examination.

Authors:  Enas A El Saftawy
Journal:  J Parasit Dis       Date:  2020-11-10

8.  Additional Evaluation of the Point-of-Contact Circulating Cathodic Antigen Assay for Schistosoma mansoni Infection.

Authors:  Pauline N M Mwinzi; Nupur Kittur; Elizabeth Ochola; Philip J Cooper; Carl H Campbell; Charles H King; Daniel G Colley
Journal:  Front Public Health       Date:  2015-03-19

9.  Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children (SchistoSAM): protocol of a proof-of-concept, open-label, two-arm, individually-randomised controlled trial.

Authors:  Clémentine Roucher; Isabel Brosius; Katja Polman; Emmanuel Bottieau; Moustapha Mbow; Babacar Thiendella Faye; Annelies De Hondt; Bart Smekens; Diana Arango; Christophe Burm; Achilleas Tsoumanis; Linda Paredis; Yven van Herrewege; Idzi Potters; Badara Cisse; Souleymane Mboup
Journal:  BMJ Open       Date:  2021-06-24       Impact factor: 2.692

10.  Diagnosis of neglected tropical diseases among patients with persistent digestive disorders (diarrhoea and/or abdominal pain ≥14 days): Pierrea multi-country, prospective, non-experimental case-control study.

Authors:  Katja Polman; Sören L Becker; Emilie Alirol; Nisha K Bhatta; Narayan R Bhattarai; Emmanuel Bottieau; Martin W Bratschi; Sakib Burza; Jean T Coulibaly; Mama N Doumbia; Ninon S Horié; Jan Jacobs; Basudha Khanal; Aly Landouré; Yodi Mahendradhata; Filip Meheus; Pascal Mertens; Fransiska Meyanti; Elsa H Murhandarwati; Eliézer K N'Goran; Rosanna W Peeling; Raffaella Ravinetto; Suman Rijal; Moussa Sacko; Rénion Saye; Pierre H H Schneeberger; Céline Schurmans; Kigbafori D Silué; Jarir A Thobari; Mamadou S Traoré; Lisette van Lieshout; Harry van Loen; Kristien Verdonck; Lutz von Müller; Cédric P Yansouni; Joel A Yao; Patrick K Yao; Peiling Yap; Marleen Boelaert; François Chappuis; Jürg Utzinger
Journal:  BMC Infect Dis       Date:  2015-08-18       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.